1 蒙丽娜, 罗婷, 柯浩, 等. DNA甲基转移酶抑制剂在动物体细胞核移植研究中的应用[J]. 中国畜牧兽医, 2012, 39(12): 133~136.2 Baylin S B, Jones P A. A decade of exploring the cancer epigenome-biological and translational implications[J]. Nature Reviews Cancer, 2011, 11(10): 726~734.3 Bert S A, Robinson M D, Strbenac D, et al. Regional activation of the cancer genome by long-range epigenetic remodeling[J]. Cancer Cell, 2012, 23(1): 9~22.4 Cedar H, Bergman Y. Programming of DNA methylation patterns[J]. Annual Review of Biochemistry, 2012, 81: 97~117.5 Clark S J, Melki J. DNA methylation and gene silencing in cancer: Which is the guilty party[J]. Oncogene, 2002, 21(35): 5380~5387.6 Coolen M W, Stirzaker C, Song J Z, et al. Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity[J]. Nature Cell Biology, 2010, 12(3): 235~246.7 Cortessis V K, Thomas D C, Levine A J, et al. Environmental epigenetics: Prospects for studying epigenetic mediation of exposure-response relationships[J]. Human Genetics, 2012, 131(10): 1565~1589.8 Dietz D M, LaPlant Q, Watts E L, et al. Paternal transmission of stress-induced pathologies[J]. Biological Psychiatry, 2011, 70(5): 408~414.9 Dowen R H, Pelizzola M, Schmitz R J, et al. Widespread dynamic DNA methylation in response to biotic stress[J]. PNAS, 2012, 109(32): E2183~E2191.10 Feinberg A P, Gehrke C W, Kuo K C, et al. Reduced genomic 5-methylcytosine content in human colonic neoplasia[J]. Cancer Research, 1988, 48(5): 1159~1161.11 He Y F, Li B Z, Li Z, et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA[J]. Science, 2011, 333(6047): 1303~1307.12 Ito S, Shen L, Dai Q, et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine[J]. Science, 2011, 333(6047): 1300~1303.13 Jiang L, Zhang J, Wang J J, et al. Sperm, but not oocyte, DNA methylome is inherited by zebrafish early embryos[J]. Cell, 2013, 153(4): 773~784.14 Kim M S, Lee J, Sidransky D. DNA methylation markers in colorectal cancer[J]. Cancer and Metastasis Reviews, 2010, 29(1): 181~206.15 Ley T J, Ding L, Walter M J, et al. DNMT3A mutations in acute myeloid leukemia[J]. NEJM, 2010, 363(25): 2424~2433.16 Lister R, Mukamel E A, Nery J R, et al. Global epigenomic reconfiguration during mammalian brain development[J]. Science, 2013, 341(6146): 626~627.17 Nigro J M, Baker S J, Preisinger A C, et al. Mutations in the p53 gene occur in diverse human tumour types[J]. Nature, 1989, 342(6250): 705~708.18 Nishigaki M, Aoyagi K, Danjoh I, et al. Discovery of aberrant expression of R-RAS by cancer-linked DNA hypomethylation in gastric cancer using microarrays[J]. Cancer Research, 2005, 65(6): 2115~2124.19 Petanjek Z, Kostovi〖KG-*4〗c〖DD(-1*2〗〖HT5〗'〖DD)〗 I. Epigenetic regulation of fetal brain development and neurocognitive outcome[J]. PNAS, 2012, 109(28): 11062~11063.20 Ray M K, Wang Y, Borowsky M, et al. Identifying candidate ncRNAs that direct changes in chromatin structure[J]. Epigenetics & Chromatin, 2013, 6(1): 69.21 Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development[J]. Nature, 2007, 447(7143): 425~432.22 Ross J P, Rand K N, Molloy P L. Hypomethylation of repeated DNA sequences in cancer[J]. Epigenomics, 2010, 2(2): 245~269.23 Seisenberger S, Andrews S, Krueger F, et al. The dynamics of genome-wide DNA methylation reprogramming in mouse primordial germ cells[J]. Molecular Cell, 2012, 48: 849~862.24 Shen L, Wu H, Diep D, et al. Genome-wide analysis reveals TET- and TDG-dependent 5-methylcytosine oxidation dynamics[J]. Cell, 2013, 153(3): 692~706.25 Song C X, Szulwach K E, Dai Q, et al. Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming[J]. Cell, 2013, 153: 1~14.26 Tan S L, Nishi M, Ohtsuka T, et al. Essential roles of the histone methyltransferase ESET in the epigenetic control of neural progenitor cells during development[J]. Development, 2012, 139(20): 3806~3816.27 Trimarchi M P, Mouangsavanh M, Huang T H. Cancer epigenetics: A perspective on the role of DNA methylation in acquired endocrine resistance[J]. CJC, 2011, 30(11): 749.28 Wang T, Wu H, Li Y, et al. Subtelomeric hotspots of aberrant 5-hydroxymethylcytosine-mediated epigenetic modifications during reprogramming to pluripotency[J]. Nature Cell Biology, 2013, 15(6): 700~711.29 Weng Y L, An R, Shin J, et al. DNA modifications and neurological disorders[J]. Neurotherapeutics, 2013, 10(4): 556~567. |